In his first week as President of the United States (US), Donald Trump has made drastic decisions with far-reaching consequences. On the first day of his term, he announced plans to withdraw from the World Health Organization (WHO). Days later, the US State Department reinstated the global gag rule and issued a freeze on foreign aid, leading, among other things, to a devastating halt in the distribution of life-saving HIV drugs by PEPFAR. Although it is difficult to keep up with rapidly changing developments, it is clear that these decisions by one of the largest donors in global health directly impacts the health of millions of people in the world. Governments around the world must step up to sustain current funding in the short term, while working towards a more sustainable global health system in the future.
The withdrawal from the World Health Organization
Let’s first look at the WHO. The organization plays a critical role in global health by sharing knowledge, setting healthcare guidelines, advising governments, and combating infectious diseases. As the only organization in global health where (almost) all countries have a seat at the table, it facilitates rapid information sharing on outbreaks. This enhances fast development of diagnostics and medicines and adequate responses to local outbreaks, preventing them to become a pandemic.
The US decision to withdraw from the WHO is deeply concerning. As a founding member and its largest funder, contributing around one fifth of the budget, this move jeopardizes an already underfunded organization. Reduced funding will severely compromise its ability to detect and respond to outbreaks like mpox and the Marburg virus, eradicate polio, and support essential health programmes, including maternal care and mental . The instructions for staff at the US Centres for Disease Control to stop all communications with WHO will also have a direct effect. It severely hampers sharing of critical information, for instance on the bird flu outbreak in the US itself, thus posing a serious global health risk.
The impact of the US foreign aid freeze
The US has been a corner stone in global health for decades, contributing to improved health outcomes through its foreign aid programmes, including many health programmes. In 2023, the US spent 0,27% of GNI on official development assistance, including health programmes. Even though other countries spent more in relative terms – Germany spent 0.8% of GNI in 2023 – the size of the US economy makes it the largest donor in absolute terms. Some global health initiatives rely heavily on US funding. For example, the 2023-2025 replenishment round for the Global Fund secured 14.4 billion USD, of which 6 billion USD was pledged by the US.
The sudden freeze on official development assistance and the accompanying stop-work order for existing grants and programmes will have devastating consequences. In low-income countries many people depend on US supported programmes for access to health services and life-saving medications. PEPFAR, for example, has provided 20.6 million people with access to HIV-medication in 2023 alone. Trumps decision shocked the world: clinics stopped issuing HIV medications, even though they were laying on the shelf. Then, on Wednesday 29 January, a waiver was anounced, allowing for the distribution of HIV medications, but leaving uncertainty about preventive drugs and other PEPFAR services.
If the freeze continues or results in significant budget cuts, the implications will not be limited to low-income countries. Fragile regions could destabilize, disease outbreaks may increase, and limited surveillance capacity could allow epidemics to rebound, threatening global health security – including in the US.